Total Payments
$12,898
2024 Payments
$4,683
Companies
22
Transactions
109
Medicare Patients
23,854
Medicare Billing
$14.7M
Payment Breakdown by Category
Food & Beverage$4,726 (36.6%)
Consulting$3,990 (30.9%)
Travel$2,256 (17.5%)
Other$1,892 (14.7%)
Education$34.25 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,726 | 98 | 36.6% |
| Consulting Fee | $3,990 | 1 | 30.9% |
| Travel and Lodging | $2,256 | 7 | 17.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,892 | 2 | 14.7% |
| Education | $34.25 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $4,850 | 7 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $2,235 | 6 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $2,118 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $692.74 | 15 | $0 (2024) |
| Genentech USA, Inc. | $656.28 | 20 | $0 (2024) |
| Allergan, Inc. | $296.97 | 11 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $256.70 | 6 | $0 (2019) |
| ABBVIE INC. | $254.81 | 8 | $0 (2024) |
| NotalVision | $223.29 | 1 | $0 (2018) |
| Spark Therapeutics, Inc. | $208.56 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,683 | 28 | EyePoint Pharmaceuticals US, Inc. ($2,046) |
| 2023 | $5,880 | 24 | Genentech, Inc. ($4,647) |
| 2022 | $206.96 | 6 | Apellis Pharmaceuticals, Inc. ($97.95) |
| 2021 | $230.72 | 6 | Regeneron Healthcare Solutions, Inc. ($140.02) |
| 2020 | $137.11 | 6 | Allergan, Inc. ($57.24) |
| 2019 | $303.72 | 12 | Novartis Pharmaceuticals Corporation ($88.29) |
| 2018 | $887.16 | 14 | NotalVision ($223.29) |
| 2017 | $569.03 | 13 | Hoffmann-La Roche Limited ($150.78) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: EYE CARE | ||||||
| 12/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: EYE CARE | ||||||
| 12/05/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | Cash or cash equivalent | $183.68 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 12/05/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | Cash or cash equivalent | $125.88 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $594.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $398.18 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $398.18 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $345.75 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/01/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: Ophthalmology | ||||||
| 09/29/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $96.00 | General |
| Category: NEUROLOGY | ||||||
| 09/29/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: EYE CARE | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $946.00 | General |
| Category: Ophthalmology | ||||||
| 08/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/26/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $946.00 | General |
| Category: Ophthalmology | ||||||
| 06/20/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Ophthalmology | ||||||
| 05/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $111.27 | General |
| Category: EYE CARE | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $35.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 6,189 | 27,295 | $18.0M | $4.2M |
| 2022 | 15 | 6,531 | 20,446 | $12.6M | $3.8M |
| 2021 | 13 | 5,642 | 18,027 | $8.4M | $3.4M |
| 2020 | 16 | 5,492 | 16,876 | $6.0M | $3.3M |
Total Patients
23,854
Total Services
82,644
Medicare Billing
$14.7M
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 276 | 3,178 | $7.9M | $2.2M | 27.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,585 | 4,039 | $1.5M | $420,493 | 28.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 90 | 2,212 | $2.2M | $415,706 | 18.8% |
| J3590 | Unclassified biologics | Office | 2023 | 65 | 104 | $786,500 | $256,489 | 32.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 400 | 2,155 | $1.3M | $234,983 | 17.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 21 | 7,260 | $907,500 | $195,458 | 21.5% |
| 92134 | Imaging of retina | Office | 2023 | 1,636 | 3,977 | $1.8M | $141,228 | 7.9% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 61 | 647 | $644,600 | $139,312 | 21.6% |
| J3490 | Unclassified drugs | Office | 2023 | 18 | 59 | $332,400 | $105,874 | 31.9% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 1,230 | 2,696 | $310,040 | $35,622 | 11.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 201 | 201 | $94,470 | $25,395 | 26.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 532 | 648 | $81,000 | $12,990 | 16.0% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 15 | 59 | $45,264 | $4,465 | 9.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 28 | 29 | $10,817 | $3,242 | 30.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 15 | 15 | $6,465 | $1,306 | 20.2% |
| 92250 | Photography of the retina | Office | 2023 | 16 | 16 | $3,104 | $494.48 | 15.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 251 | 3,006 | $5.8M | $2.1M | 37.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 114 | 3,438 | $2.8M | $756,393 | 27.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,399 | 3,137 | $951,832 | $357,772 | 37.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 371 | 1,980 | $1.2M | $216,560 | 18.0% |
| 92134 | Imaging of retina | Office | 2022 | 1,642 | 4,075 | $1.2M | $145,810 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 559 | 723 | $146,206 | $46,972 | 32.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 1,164 | 2,854 | $238,618 | $38,753 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 231 | 231 | $86,810 | $28,799 | 33.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 596 | 729 | $66,521 | $14,567 | 21.9% |
About Dr. Michael Lai, MD
Dr. Michael Lai, MD is a Ophthalmology healthcare provider based in Chevy Chase, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962432260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lai, MD has received a total of $12,898 in payments from pharmaceutical and medical device companies, with $4,683 received in 2024. These payments were reported across 109 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,726).
As a Medicare-enrolled provider, Lai has provided services to 23,854 Medicare beneficiaries, totaling 82,644 services with total Medicare billing of $14.7M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmology
- Location Chevy Chase, MD
- Active Since 07/03/2006
- Last Updated 04/09/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1962432260
Products in Payments
- Susvimo (Drug) $4,673
- Syfovre (Drug) $2,137
- EYP-1901 (Drug) $2,046
- OZURDEX (Drug) $551.78
- Vabysmo (Drug) $412.64
- EYLEA (Biological) $377.31
- Lucentis (Biological) $351.04
- EYLEA HD (Biological) $239.32
- ForeseeHome (Device) $223.29
- Non-Covered Product (Drug) $174.73
- EYLEA AFLIBERCEPT INJECTION (Biological) $170.07
- INSPIRE (Device) $132.25
- ENTRESTO (Drug) $121.62
- LUXTURNA (Biological) $116.55
- OMNI SURGICAL SYSTEM (Device) $103.99
- TYRVAYA (Drug) $95.24
- BEOVU (Drug) $66.65
- XARELTO (Drug) $64.02
- Resolute (Device) $56.28
- Iluvien (Biological) $54.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Chevy Chase
Thomas Clinch, Md, MD
Ophthalmology — Payments: $248,965
Ophthalmology $248,965
Dr. Anand Mantravadi, M.d, M.D
Ophthalmology — Payments: $135,695
Ophthalmology $135,695
Dr. Hylton Mayer, M. D, M. D
Ophthalmology — Payments: $96,221
Ophthalmology $96,221
Dr. Brian Do, M.d, M.D
Ophthalmology — Payments: $94,769
Ophthalmology $94,769
Neil Martin, Md, MD
Ophthalmology — Payments: $13,932
Ophthalmology $13,932
Dr. Kenneth Schor, M.d, M.D
Ophthalmology — Payments: $13,226
Ophthalmology $13,226